Unjha Formulations Ltd
Incorporated in 1991, Unjha Formulations Ltd is a manufacturer and exporter of psyllium husk-based products.[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/OP |
Ratios
Figures in Rs. Crores
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Actual Production - Powder kg ・Standalone data |
|
||||||||||
| Actual Production - Tablets Nos ・Standalone data |
|||||||||||
| Number of Permanent Employees Numbers ・Standalone data |
|||||||||||
| Installed Capacity - Powder Lacs kg ・Standalone data |
|||||||||||
| Installed Capacity - Tablets Crores Nos ・Standalone data |
|||||||||||
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
10 Apr - Submitted Regulation 74(5) confirmation certificate for quarter ended 31 March 2026.
-
Disclosures Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And
Takeovers) Regulations, 2011.
2 Apr - Company received Regulation 31(4) disclosures from promoters and promoter group as of 01.04.2026.
-
Disclosures Under Regulation 30(1) And 30(2) Of SEBI (Substantial Acquisition Of Shares &Takeovers) Regulations, 2011
2 Apr - Company received SEBI SAST disclosures from promoters and promoter group as on 01.04.2026.
-
Closure of Trading Window
2 Apr - Trading window closed from 1 April 2026 until 48 hours after FY26 audited results.
-
:Publish Un-Audited Financial Results For The Quarter & Nine Month Ended As On 31/12/2025
5 Feb - Surat builder Tushar Ghelani shot himself Feb 1; 9mm bullet through brain; condition critical at Mahavir Hospital.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
UFL is a part of M/s Urvesh Ltd. It is a GMP-certified manufacturer and exporter of Isabgol (Psyllium) and Ayurvedic formulation products.
The company also manufactures all kinds of small-volume Ayurvedic Isabgol (Psyllium) powder.